English | 繁體

Search in the results

UM

Browse/Search Results:  1-5 of 5 Help

Selected(0)Clear Items/Page:    Sort:
Lentinan-Based Oral Nanoparticle Loaded Budesonide With Macrophage-Targeting Ability for Treatment of Ulcerative Colitis Journal article
Lin, Meisi, Dong, Lingling, Chen, Qiyan, Xu, Haiting, Han, Xiaoqin, Luo, Ruifeng, Pu, Xiulan, Qi, Shanshan, Nie, Wenbiao, Ma, Meilin, Wang, Yitao, Gao, Fei, Zhang, Jinming. Lentinan-Based Oral Nanoparticle Loaded Budesonide With Macrophage-Targeting Ability for Treatment of Ulcerative Colitis[J]. Frontiers in Bioengineering and Biotechnology, 2021, 9, 702173.
Authors:  Lin, Meisi;  Dong, Lingling;  Chen, Qiyan;  Xu, Haiting;  Han, Xiaoqin; et al.
Favorite | TC[WOS]:27 TC[Scopus]:27  IF:4.3/5.1 | Submit date：2021/12/08
Lentinan  Budesonide  Macrophage-target  Oral Nanoparticles  Ulcerative Colitis  
Nanoparticles Mediating the Sustained Release of Ginkgolide B Offer Improved Brain Accumulation and Anti-Parkinsonian Activity Conference paper
Zhao, Yuying, Xiong, Sha, Liu, Wei, Liu, Yao, Wang, Qun, Luo, Jingshan, Chen, Xiaojia, Chen, Tonakai. Nanoparticles Mediating the Sustained Release of Ginkgolide B Offer Improved Brain Accumulation and Anti-Parkinsonian Activity[C], Yantai:The 13th Chinese Pharmaceutical Conference, 2019.
Authors:  Zhao, Yuying;  Xiong, Sha;  Liu, Wei;  Liu, Yao;  Wang, Qun; et al.
Favorite |  | Submit date：2022/08/02
Parkinson's Disease  Peg-pcl Nanoparticles  Ginkgolide b  Oral Bioavailability  Anti-parkinsonian Efficacy  Brain Delivery  
Star-Shaped PLGA nanoparticles of puerarin with sustained release to improve oral bioavailability and anti-Parkinsonian efficacy Conference paper
Chen, Tongkai, Liu, Wei, Xiong, Sha, Chen, Xiaojia, Wang, Qi. Star-Shaped PLGA nanoparticles of puerarin with sustained release to improve oral bioavailability and anti-Parkinsonian efficacy[C], Shanghai:The 3rd International Conference on Nanomedicine, 2018.
Authors:  Chen, Tongkai;  Liu, Wei;  Xiong, Sha;  Chen, Xiaojia;  Wang, Qi
Favorite |  | Submit date：2022/08/02
Star-shaped Plga Nanoparticles  Puerarin  Oral Bioavailability  Brain Delivery  Parkinson's Disease  
Small-Sized mPEG PLGA Nanoparticles of Schisantherin A with Sustained Release for Enhanced Brain Uptake and Anti-Parkinsonian Activity Journal article
Chen, Tongkai, Li, Chuwen, Li, Ye, Yi, Xiang, Wang, Ruibing, Lee, Simon Ming-Yuen, Zheng, Ying. Small-Sized mPEG PLGA Nanoparticles of Schisantherin A with Sustained Release for Enhanced Brain Uptake and Anti-Parkinsonian Activity[J]. ACS APPLIED MATERIALS & INTERFACES, 2017, 9(11), 9516-9527.
Authors:  Chen, Tongkai;  Li, Chuwen;  Li, Ye;  Yi, Xiang;  Wang, Ruibing; et al.
Favorite | TC[WOS]:70 TC[Scopus]:79  IF:8.3/8.7 | Submit date：2018/10/30
Brain Delivery  Cellular Uptake  Fluorescence Resonance Energy Transfer (Fret)  Mpeg-plga Nanoparticles  Oral Bioavailability  Schisantherin a  
Small-Sized mPEG-PLGA Nanoparticles of Schisantherin A with Sustained Release for Enhanced Brain Uptake and Anti-Parkinsonian Activity Journal article
Tongkai Chen, Chuwen Li, Ye Li, Xiang Yi, Ruibing Wang, Simon Ming-Yuen Lee, Ying Zheng. Small-Sized mPEG-PLGA Nanoparticles of Schisantherin A with Sustained Release for Enhanced Brain Uptake and Anti-Parkinsonian Activity[J]. ACS Applied Materials and Interfaces, 2017, 9(11), 9516-9527.
Authors:  Tongkai Chen;  Chuwen Li;  Ye Li;  Xiang Yi;  Ruibing Wang; et al.
Favorite | TC[WOS]:70 TC[Scopus]:79  IF:8.3/8.7 | Submit date：2018/12/28
Brain Delivery  Cellular Uptake  Fluorescence Resonance Energy Transfer (Fret)  Mpeg−plga Nanoparticles  Oral Bioavailability  Schisantherin a